CME Group Buys CMA for OTC Data Play

The acquisition, which closed on Sunday, March 23, "diversifies the CME as a company, and gives us exposure to the large and fast-growing OTC derivatives market... [where] we can add value in terms of leveraging our technology and transaction processing capabilities," says a CME spokesperson.

CME participants "are looking for tools like [those of] CMA that help them make better trading decisions" in the credit markets, which remain relatively opaque, the spokesperson says. "This is another a

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: